• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Tethys BioScience

edit

Tethys BioScience, Inc. engages in the discovery, development, and commercialization of biological markers. Its products are used to diagnosis the metabolic diseases, such as diabetes. The company offers PreDx Diabetes Risk Test, a diagnostic test that analyzes a set of multiple proteins and other blood borne biomarkers implicated in the development of diabetes. Tethys BioScience, Inc. was founded in 2002 and is based in Emeryville, California.

Recent Milestones

edit

• 
  Tethys BioScience added Randy Strahan as President & Chief Executive Officer & Board Member. (2/1/11)
  Posted 5/6/13 at 12:29am
• 
  Tethys BioScience added David Hodgson as Chief Information Officer. (6/1/10)
  Posted 10/14/10 at 10:11pm
• 
  Tethys BioScience received $25M in Series D funding. (11/9/09)
  Posted 11/10/09 at 2:31am via venturebeat.com
• 
  Tethys BioScience acquired Lipomics Technologies. (9/17/08)
  Posted 9/11/09 at 7:18am via lipomics.com
• 
  Tethys BioScience received $5.4M in Series A funding. (10/31/05)
  Posted 8/30/10 at 4:51am
• 
  Tethys BioScience added Mickey S. Urdea as Co - Founder .
  Posted 9/11/09 at 7:18am
• 
  Tethys BioScience added Dr .Urdea as Founder & Chief Executive Officer.
  Posted 4/24/13 at 12:31pm
• 
  Tethys BioScience added R. Michael Richey as President .
  Posted 9/11/09 at 7:18am

Videos

Screenshots

edit

Sources

1. Tethys Bioscience Announces Acquisition of Lipomics Technologies (lipomics.com) [edit]
2. EDGAR [edit]
3. Tethys picks up $25M for diabetes diagnostic (deals.venturebeat.com) [edit]